BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $138 at Jefferies

August 5, 2020 4:47 AM

Jefferies analyst Eun Yang raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $138.00 (from $132.00) while maintaining a Buy rating.

No results found